{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:31:37Z","timestamp":1791318697712,"version":"4.3.1"},"reference-count":95,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Multidrug (MDR) and extensive drug (XDR) resistance in Gram-negative bacteria (GNB) emerges worldwide. Although bone and joint infections are mostly caused by Gram-positive bacteria, mainly Staphylococci, MDR GNB substantially increase also as a complication of hospitalization and previous antibiotic administration. This narrative review analyzes the epidemiological trend, current experimental data, and clinical experience with available therapeutic options for the difficult to treat (DTR) GNB implicated in bone and joint infections with or without orthopedic implants. The radical debridement and removal of the implant is adequate therapy for most cases, along with prompt and prolonged combined antimicrobial treatment by older and novel antibiotics. Current research and clinical data suggest that fluoroquinolones well penetrate bone tissue and are associated with improved outcomes in DTR GNB; if not available, carbapenems can be used in cases of MDR GNB. For XDR GNB, colistin, fosfomycin, tigecycline, and novel \u03b2-lactam\/\u03b2-lactamase inhibitors can be initiated as combination schemas in intravenous administration, along with local elution from impregnated spacers. However, current data are scarce and large multicenter studies are mandatory in the field.<\/jats:p>","DOI":"10.3390\/pathogens14020130","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T04:36:51Z","timestamp":1738557411000},"page":"130","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Antimicrobial Treatment Options for Multidrug Resistant Gram-Negative Pathogens in Bone and Joint Infections"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8751-4711","authenticated-orcid":false,"given":"Maria","family":"Tsilika","sequence":"first","affiliation":[{"name":"1st Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3369-876X","authenticated-orcid":false,"given":"Fotinie","family":"Ntziora","sequence":"additional","affiliation":[{"name":"1st Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2715-7457","authenticated-orcid":false,"given":"Efthymia","family":"Giannitsioti","sequence":"additional","affiliation":[{"name":"1st Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Antimicrobial Resistance Collaborators Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","author":"Ranjbar","year":"2022","journal-title":"Lancet Lond. Engl."},{"key":"ref_2","first-page":"268","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Coskun, B., Ayhan, M., Bozer, M., Ozaslan, H.I., Dogan, M., Citak, M., and Akkaya, M. (2024). What Is the Rate of Antimicrobial Resistance of a Prosthetic Joint Infection in a Major Orthopaedic Centre?. Antibiot. Basel Switz., 13.","DOI":"10.3390\/antibiotics13040306"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S521","DOI":"10.1093\/cid\/ciz824","article-title":"Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria","volume":"69","author":"Nordmann","year":"2019","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e00031-19","DOI":"10.1128\/CMR.00031-19","article-title":"Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections","volume":"32","author":"Horcajada","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/jac\/dkz147","article-title":"Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology","volume":"74","author":"Zamorano","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e00202-21","DOI":"10.1128\/mSphere.00202-21","article-title":"Epidemiology of Multidrug-Resistant Pseudomonas aeruginosa in the Middle East and North Africa Region","volume":"6","author":"Hadi","year":"2021","journal-title":"mSphere"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3201\/eid2406.171648","article-title":"Genomic Epidemiology of Global Carbapenemase-Producing Enterobacter spp., 2008\u20132014","volume":"24","author":"Peirano","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"ref_9","first-page":"353","article-title":"Microbiologic epidemiology depending on time to occurrence of prosthetic joint infection: A prospective cohort study","volume":"25","author":"Ferry","year":"2019","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"ref_10","first-page":"732.e1","article-title":"Time trends in the aetiology of prosthetic joint infections: A multicentre cohort study","volume":"22","author":"Benito","year":"2016","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.arth.2017.01.027","article-title":"Specific Infectious Organisms Associated with Poor Outcomes in Treatment for Hip Periprosthetic Infection","volume":"32","author":"Cunningham","year":"2017","journal-title":"J. Arthroplasty"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Macias-Valcayo, A., Aguilera-Correa, J.-J., Broncano, A., Parron, R., Au\u00f1on, A., Garcia-Ca\u00f1ete, J., Blanco, A., and Esteban, J. (2022). Comparative In Vitro Study of Biofilm Formation and Antimicrobial Susceptibility in Gram-Negative Bacilli Isolated from Prosthetic Joint Infections. Microbiol. Spectr., 10.","DOI":"10.1128\/spectrum.00851-22"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"da Silva, R.B., and Salles, M.J. (2021). Outcomes and Risk Factors in Prosthetic Joint Infections by multidrug-resistant Gram-negative Bacteria: A Retrospective Cohort Study. Antibiotics, 10.","DOI":"10.3390\/antibiotics10030340"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijantimicag.2018.10.018","article-title":"Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration","volume":"53","author":"Papadopoulos","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5194\/jbji-7-279-2022","article-title":"Osteosynthesis-associated infection of the lower limbs by multidrug-resistant and extensively drug-resistant Gram-negative bacteria: A multicentre cohort study","volume":"7","author":"Giannitsioti","year":"2022","journal-title":"J. Bone Jt. Infect."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Manche\u00f1o-Losa, M., Murillo, O., Benavent, E., Sorl\u00ed, L., Riera, M., Cobo, J., Benito, N., Morata, L., Ribera, A., and Sobrino, B. (2024). Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: A prospective multicenter study. Infection.","DOI":"10.1007\/s15010-024-02379-7"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.7754\/Clin.Lab.2024.240333","article-title":"Analysis of Pathogen Distribution and Antimicrobial Resistance in Bone and Joint Infections Among Young Children","volume":"70","author":"Chen","year":"2024","journal-title":"Clin. Lab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: A common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/pathogens2020288","article-title":"From in vitro to in vivo Models of Bacterial Biofilm-Related Infections","volume":"2","author":"Lebeaux","year":"2013","journal-title":"Pathogens"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-3-030-16373-0_13","article-title":"Clinical Use of Colistin in Biofilm-Associated Infections","volume":"1145","author":"Murillo","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-200948020-00002","article-title":"Penetration of antibacterials into bone: Pharmacokinetic, pharmacodynamic and bioanalytical considerations","volume":"48","author":"Landersdorfer","year":"2009","journal-title":"Clin. Pharmacokinet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1128\/AAC.00296-11","article-title":"Carbapenems: Past, Present, and Future","volume":"55","author":"Endimiani","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Tamma, P.D., Heil, E.L., Justo, J.A., Mathers, A.J., Satlin, M.J., and Bonomo, R.A. (2024). Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., ciae403.","DOI":"10.1093\/cid\/ciae403"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"106856","DOI":"10.1016\/j.ijantimicag.2023.106856","article-title":"Efficacy of meropenem extended infusion vs intermittent bolus monotherapy and in combination with colistin against Pseudomonas aeruginosa biofilm","volume":"62","author":"Benavent","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1128\/AAC.06486-11","article-title":"In vivo pharmacokinetics\/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection","volume":"56","author":"Hengzhuang","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"106152","DOI":"10.1016\/j.ijantimicag.2020.106152","article-title":"Efficacy of generic meropenem products in combination with colistin in carbapenemase-producing Klebsiella pneumoniae experimental osteomyelitis","volume":"56","author":"Tattevin","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s11739-021-02749-1","article-title":"Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections","volume":"16","author":"Matlock","year":"2021","journal-title":"Intern. Emerg. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Bassetti, M., Vena, A., Sepulcri, C., Giacobbe, D.R., and Peghin, M. (2020). Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance. Antibiotics, 9.","DOI":"10.3390\/antibiotics9090632"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Laffont-Lozes, P., Naciri, T., Pantel, A., Martin, A., Pruvot-Occean, A.-S., Haignere, V., Loubet, P., Sotto, A., and Larcher, R. (2024). First case report of a vertebral osteomyelitis caused by carbapenem-resistant Enterobacter cloacae treated with imipenem\/cilastatin\/relebactam prolonged infusion then meropenem\/vaborbactam in continuous infusion. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1347306"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ijantimicag.2019.01.010","article-title":"Efficacy of ceftolozane\/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model","volume":"53","author":"Benavent","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/jac\/dkad070","article-title":"Efficacy of ceftazidime\/avibactam in various combinations for the treatment of experimental osteomyelitis in rabbits caused by OXA-48-\/ESBL-producing Escherichia coli","volume":"78","author":"Davido","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"106702","DOI":"10.1016\/j.ijantimicag.2022.106702","article-title":"Efficacy of ceftazidime-avibactam in various combinations for the treatment of experimental osteomyelitis due to Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae","volume":"61","author":"Davido","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e02031-18","DOI":"10.1128\/AAC.02031-18","article-title":"In Vivo Pharmacodynamic Study of Cefiderocol, a Novel Parenteral Siderophore Cephalosporin, in Murine Thigh and Lung Infection Models","volume":"63","author":"Nakamura","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40265-019-1055-2","article-title":"Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli","volume":"79","author":"Zhanel","year":"2019","journal-title":"Drugs"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jgar.2024.01.021","article-title":"Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa","volume":"37","author":"Ferretti","year":"2024","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/jbcr\/irae026","article-title":"Bone and Skin\/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosa","volume":"45","author":"Mueller","year":"2024","journal-title":"J. Burn Care Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kowalska-Krochmal, B., M\u0105czy\u0144ska, B., Rura\u0144ska-Smutnicka, D., Secewicz, A., Krochmal, G., Bartelak, M., G\u00f3rzy\u0144ska, A., Laufer, K., Woronowicz, K., and \u0141ubniewska, J. (2022). Assessment of the Susceptibility of Clinical Gram-Negative and Gram-Positive Bacterial Strains to Fosfomycin and Significance of This Antibiotic in Infection Treatment. Pathogens, 11.","DOI":"10.3390\/pathogens11121441"},{"key":"ref_38","first-page":"30","article-title":"The role of fosfomycin in osteoarticular infection","volume":"32","author":"Morata","year":"2019","journal-title":"Rev. Esp. Quimioter."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1093\/jac\/dkac142","article-title":"Activity of fosfomycin\/colistin combinations against planktonic and biofilm Gram-negative pathogens","volume":"77","author":"Boncompagni","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1586\/eri.12.78","article-title":"Colistin: An update on the antibiotic of the 21st century","volume":"10","author":"Biswas","year":"2012","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/phar.2209","article-title":"International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)","volume":"39","author":"Tsuji","year":"2019","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1093\/jac\/dkz257","article-title":"Efficacy of colistin alone and in various combinations for the treatment of experimental osteomyelitis due to carbapenemase-producing Klebsiella pneumoniae","volume":"74","author":"Dinh","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s40265-022-01676-5","article-title":"Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review","volume":"82","author":"Chou","year":"2022","journal-title":"Drugs"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.medmal.2017.09.001","article-title":"Tigecycline-based prolonged salvage therapy in patients presenting with complex bone and joint infection","volume":"48","author":"Wach","year":"2018","journal-title":"Med. Mal. Infect."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1128\/AAC.01718-12","article-title":"Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-\u03b2-lactamase-producing Escherichia coli in a foreign-body infection model","volume":"57","author":"Corvec","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1128\/AAC.39.11.2423","article-title":"Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination","volume":"39","author":"Brouqui","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_47","first-page":"1030","article-title":"Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combination","volume":"12","author":"Legout","year":"2006","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1179\/joc.2009.21.2.226","article-title":"Chronic bone infections due to Enterobacter cloacae: Current therapeutic trends and clinical outcome","volume":"21","author":"Kanellakopoulou","year":"2009","journal-title":"J. Chemother. Florence Italy"},{"key":"ref_49","first-page":"O911","article-title":"Gram-negative prosthetic joint infection: Outcome of a debridement, antibiotics and implant retention approach. A large multicentre study","volume":"20","author":"Pigrau","year":"2014","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1128\/AAC.00188-09","article-title":"Outcome of acute prosthetic joint infections due to gram-negative bacilli treated with open debridement and retention of the prosthesis","volume":"53","author":"Vilchez","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1093\/jac\/dkw202","article-title":"Gram-negative prosthetic joint infections managed according to a multidisciplinary standardized approach: Risk factors for failure and outcome with and without fluoroquinolones","volume":"71","author":"Grossi","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_52","first-page":"3357","article-title":"Osteoarticular infection caused by MDR Pseudomonas aeruginosa: The benefits of combination therapy with colistin plus \u03b2-lactams","volume":"70","author":"Ribera","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijantimicag.2012.09.016","article-title":"Difficult-to-treat Gram-negative bone and joint infections: Efficacy and safety of prolonged intravenous colistin","volume":"41","author":"Valour","year":"2013","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1752-1947-8-186","article-title":"Tolerability and efficacy of long-term treatment with daptomycin, ceftazidime and colistin in a patient with a polymicrobial, multidrug-resistant prosthetic joint reinfection: A case report","volume":"8","author":"Pasticci","year":"2014","journal-title":"J. Med. Case Reports"},{"key":"ref_55","first-page":"73","article-title":"Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: A unique challenge in the era of untreatable infections","volume":"25","author":"Teixeira","year":"2014","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Pfang, B.G., Garc\u00eda-Ca\u00f1ete, J., Garc\u00eda-Lasheras, J., Blanco, A., Au\u00f1\u00f3n, \u00c1., Parron-Cambero, R., Mac\u00edas-Valcayo, A., and Esteban, J. (2019). Orthopedic Implant-Associated Infection by Multidrug Resistant Enterobacteriaceae. J. Clin. Med., 8.","DOI":"10.3390\/jcm8020220"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1086\/605593","article-title":"Gram-negative prosthetic joint infections: Risk factors and outcome of treatment","volume":"49","author":"Hsieh","year":"2009","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_58","first-page":"2332-0877","article-title":"Carbapenem-Resistant Klebsiella Pneumoniae Osteomyelitis and Soft Tissue Infections: A Descriptive Case Series","volume":"3","author":"Odio","year":"2015","journal-title":"J. Infect. Dis. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"60","DOI":"10.7150\/jbji.42448","article-title":"Tigecycline Versus Colistin in the Treatment of Carbapenem-resistant Acinetobacter baumannii Complex Osteomyelitis","volume":"5","author":"Oliveira","year":"2020","journal-title":"J. Bone Jt. Infect."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3947\/ic.2016.48.4.324","article-title":"Acinetobacter Prosthetic Joint Infection Treated with Debridement and High-Dose Tigecycline","volume":"48","author":"Vila","year":"2016","journal-title":"Infect. Chemother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"107134","DOI":"10.1016\/j.ijantimicag.2024.107134","article-title":"Intravenous fosfomycin in combination regimens as a treatment option for difficult-to-treat infections due to multi-drug-resistant Gram-negative organisms: A real-life experience","volume":"63","author":"Meschiari","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1093\/ajhp\/zxab294","article-title":"Intravenous fosfomycin as salvage therapy for osteomyelitis caused by multidrug-resistant Pseudomonas aeruginosa","volume":"78","author":"Wong","year":"2021","journal-title":"Am. J. Health. Syst. Pharm."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"ofaa572","DOI":"10.1093\/ofid\/ofaa572","article-title":"Cure of Limb-Threatening XDR Pseudomonas aeruginosa Infection: Combining Genome Sequencing, Therapeutic Drug Level Monitoring, and Surgical Debridement","volume":"8","author":"Narayanasamy","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40121-023-00762-9","article-title":"The Use and Effectiveness of Ceftazidime-Avibactam in Real-World Clinical Practice: EZTEAM Study","volume":"12","author":"Soriano","year":"2023","journal-title":"Infect. Dis. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Mancuso, A., Pipit\u00f2, L., Rubino, R., Distefano, S.A., Mangione, D., and Cascio, A. (2023). Ceftazidime-Avibactam as Osteomyelitis Therapy: A Miniseries and Review of the Literature. Antibiotics, 12.","DOI":"10.3390\/antibiotics12081328"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Vena, A., Giacobbe, D., Castaldo, N., Cattelan, A., Mussini, C., Luzzati, R., De Rosa, F., Puente, F., Mastroianni, C., and Cascio, A. (2020). Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales. Antibiotics, 9.","DOI":"10.3390\/antibiotics9020071"},{"key":"ref_67","first-page":"1854805","article-title":"Prosthetic Joint Infection from Carbapenemase-Resistant Klebsiella pneumoniae Successfully Treated with Ceftazidime-Avibactam","volume":"2018","author":"Schimmenti","year":"2018","journal-title":"Case Rep. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Merad, Y., Conrad, A., Brosset, S., Schmidt, A., Hanriat, C., Lustig, S., Laurent, F., Kolenda, C., Roussel-Gaillard, T., and Batailler, C. (2023). Case report: Continuous infusions of ceftazidime-avibactam and aztreonam in combination through elastomeric infusors for 12 weeks for the treatment of bone and joint infections due to metallo-\u03b2-lactamase producing Enterobacterales. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1224922"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Mittal, J., Szymczak, W.A., Guo, Y., Levi, M.H., Chen, L., Kreiswirth, B.N., Riska, P.F., and Nori, P. (2018). Two for the price of one: Emerging carbapenemases in a returning traveller to New York City. BMJ Case Rep.","DOI":"10.1136\/bcr-2018-225440"},{"key":"ref_70","first-page":"510","article-title":"Combination of aztreonam, ceftazidime-avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis","volume":"108","author":"Mularoni","year":"2021","journal-title":"Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e12837","DOI":"10.1111\/tid.12837","article-title":"Carbapenem-resistant Klebsiella pneumoniae vertebral osteomyelitis in a renal transplant recipient treated with ceftazidime-avibactam","volume":"20","author":"Cani","year":"2018","journal-title":"Transpl. Infect. Dis. Off. J. Transplant. Soc."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.2147\/IDR.S421209","article-title":"Carbapenem-Resistant Pseudomonas aeruginosa Spondylodiscitis Treated with Ceftazidime-Avibactam: A Case Report with Literature Review","volume":"16","author":"Danda","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref_73","first-page":"128","article-title":"Ceftazidime\/Avibactam for Refractory Bacteremia, Vertebral Diskitis\/Osteomyelitis with Pre-Vertebral Abscess and Bilateral Psoas Pyomyositis Secondary to Klebsiella Pneumoniae Carbapenemase-Producing Bacteria (KPC)","volume":"37","author":"Vidal","year":"2018","journal-title":"P. R. Health Sci. J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/23744235.2024.2387130","article-title":"Effectiveness and safety of Ceftolozane\/Tazobactam administered in continuous infusion through elastomeric pumps in OPAT regimen: A case series","volume":"56","author":"Giuliano","year":"2024","journal-title":"Infect. Dis. Lond. Engl."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jgar.2021.04.003","article-title":"Treatment of bone and joint infections by ceftazidime\/avibactam and ceftolozane\/tazobactam: A cohort study","volume":"25","author":"Rempenault","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"ofad173","DOI":"10.1093\/ofid\/ofad173","article-title":"A Real-world Multicenter Outpatient Experience of Ceftolozane\/Tazobactam","volume":"10","author":"Schroeder","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jgar.2021.09.015","article-title":"Real-world clinical outcomes of meropenem\/vaborbactam for treatment of carbapenem-resistant Enterobacterales infections","volume":"27","author":"Zhang","year":"2021","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"ofaa051","DOI":"10.1093\/ofid\/ofaa051","article-title":"Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial Infections","volume":"7","author":"Alosaimy","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Leanza, C., Mascellino, M.T., Volpicelli, L., Covino, S., Falletta, A., Cancelli, F., Franchi, C., Carnevalini, M., Mastroianni, C.M., and Oliva, A. (2024). Real-world use of imipenem\/cilastatin\/relebactam for the treatment of KPC-producing Klebsiella pneumoniae complex and difficult-to-treat resistance (DTR) Pseudomonas aeruginosa infections: A single-center preliminary experience. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1432296"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"ofaa150","DOI":"10.1093\/ofid\/ofaa150","article-title":"Case Report: Successful Rescue Therapy of Extensively Drug-Resistant Acinetobacter baumannii Osteomyelitis With Cefiderocol","volume":"7","author":"Dagher","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/phar.2660","article-title":"Successful prolonged treatment of a carbapenem-resistant Acinetobacter baumannii hip infection with cefiderocol: A case report","volume":"42","author":"Rose","year":"2022","journal-title":"Pharmacotherapy"},{"key":"ref_82","first-page":"20499361231174292","article-title":"Cefiderocol for Stenotrophomonas maltophilia prosthetic joint infection: A case report","volume":"10","author":"Chambers","year":"2023","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"dlae015","DOI":"10.1093\/jacamr\/dlae015","article-title":"Successful outpatient parenteral antibiotic therapy with cefiderocol for osteomyelitis caused by multi-drug resistant Gram-negative bacteria: A case report","volume":"6","author":"Schellong","year":"2023","journal-title":"JAC-Antimicrob. Resist."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e01872-19","DOI":"10.1128\/AAC.01872-19","article-title":"Long-Term Compassionate Use of Cefiderocol To Treat Chronic Osteomyelitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum-\u03b2-Lactamase-Producing Klebsiella pneumoniae in a Pediatric Patient","volume":"64","author":"Alamarat","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"dlac046","DOI":"10.1093\/jacamr\/dlac046","article-title":"Combination of phage therapy and cefiderocol to successfully treat Pseudomonas aeruginosa cranial osteomyelitis","volume":"4","author":"Simner","year":"2022","journal-title":"JAC-Antimicrob. Resist."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","article-title":"Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): A randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial","volume":"21","author":"Bassetti","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.arth.2006.05.006","article-title":"Management of a multidrug-resistant Pseudomonas aeruginosa infected total knee arthroplasty using colistin. A case report and review of the literature","volume":"22","author":"Papagelopoulos","year":"2007","journal-title":"J. Arthroplasty"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijantimicag.2014.05.023","article-title":"Successful treatment of extensively drug-resistant Pseudomonas aeruginosa osteomyelitis using a colistin- and tobramycin-impregnated PMMA spacer","volume":"44","author":"Krajewski","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1308\/003588414X13946184903289","article-title":"Case report of a successfully treated gentamicin and ciprofloxacin resistant Serratia marcescens prosthetic joint infection","volume":"96","author":"Cannon","year":"2014","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40001-019-0360-2","article-title":"Eradication of Acinetobacter baumannii\/Enterobacter cloacae complex in an open proximal tibial fracture and closed drop foot correction with a multidisciplinary approach using the Taylor Spatial Frame\u00ae: A case report","volume":"24","author":"Grabein","year":"2019","journal-title":"Eur. J. Med. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41467-021-27656-z","article-title":"Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae","volume":"13","author":"Eskenazi","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","article-title":"Antibiotic penetration into bone and joints: An updated review","volume":"81","author":"Thabit","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e00079-17","DOI":"10.1128\/CMR.00079-17","article-title":"Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae","volume":"31","author":"Machuca","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/14787210.2021.1932463","article-title":"Intravenous fosfomycin for the treatment of patients with bone and joint infections: A review","volume":"20","author":"Tsegka","year":"2022","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/2\/130\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:25:36Z","timestamp":1760027136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/2\/130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":95,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["pathogens14020130"],"URL":"https:\/\/doi.org\/10.3390\/pathogens14020130","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,1]]}}}